BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 4993895)

  • 1. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
    Ponzone A; Tarocco RP; Nicola P
    Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
    Berceanu S; Gociu M
    Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 5. [B lymphoproliferative syndrome with characteristics common to chronic lymphatic leukemia, Waldenström disease and plasmacytic leukemia].
    Tosato F; Fossaluzza V; Sala P; Tonutti E
    Minerva Med; 1984 Nov; 75(44):2691-4. PubMed ID: 6440066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune deficiency states associated with malignant disease in man.
    Harris J; Bagai RC
    Med Clin North Am; 1972 Mar; 56(2):501-14. PubMed ID: 4623010
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute leukemia syndromes (ALS) appearing during the evolution of hematosarcomas and chronic leukemias (clinical analysis)].
    Mathé G; Tubiana M; Calman F; Schlumberger JR; Berumen L; Choquet C; Cattan A; Schneider M
    Nouv Rev Fr Hematol; 1967; 7(4):543-54. PubMed ID: 4228678
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogenesis of infections-inflammatory complications in hemoblastoses and characteristics of their treatment].
    Loginskiĭ VE
    Ter Arkh; 1970 Sep; 42(9):52-6. PubMed ID: 5278249
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal gammopathy in lymphoma.
    Alexanian R
    Arch Intern Med; 1975 Jan; 135(1):62-6. PubMed ID: 1089397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In-vitro biosynthesis of gamma-globulins in congenital and acquired dysproteinemias].
    Aiuti F; Fontana L
    Minerva Med; 1972 Mar; 63(22):1274-80. PubMed ID: 4623012
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous immunoglobulin substitution in patients with multiple myeloma, Waldenstrom's syndrome and chronic lymphatic leukemia with secondary antibody deficiency syndrome].
    Schedel I
    Beitr Infusionther Klin Ernahr; 1983; 11():52-8. PubMed ID: 6418137
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological behavior of patients with malignant blood diseases].
    Luca N
    Stud Cercet Med Interna; 1973; 14(5):429-46. PubMed ID: 4202394
    [No Abstract]   [Full Text] [Related]  

  • 13. [Amyloidosis and immunoproliferative diseases (proceedings)].
    Lovisetto P; Ricci C; Biarese V; Molfese G
    Minerva Med; 1977 Oct; 68(51):3519-23. PubMed ID: 412142
    [No Abstract]   [Full Text] [Related]  

  • 14. The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma.
    Berg JW
    J Natl Cancer Inst; 1967 May; 38(5):741-52. PubMed ID: 5229351
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of cancer on the immune globulins and immunity.
    Fahey JL
    Proc Natl Cancer Conf; 1964; 5():417-20. PubMed ID: 4159237
    [No Abstract]   [Full Text] [Related]  

  • 16. [T-and B-lymphocytes in lymphoproliferative syndromes].
    Girard JP; Fernandes B
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1174-9. PubMed ID: 814616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 18. [The incidence of chronic lymphoid leukemia antigen in other malignant hematologic diseases].
    Do TP; Petrányi G; Hollán Z
    Orv Hetil; 1974 Apr; 115(16):930-1. PubMed ID: 4206891
    [No Abstract]   [Full Text] [Related]  

  • 19. The spectrum of B cell neoplasia.
    Deegan MJ
    Henry Ford Hosp Med J; 1984; 32(1):20-30. PubMed ID: 6204956
    [No Abstract]   [Full Text] [Related]  

  • 20. B-lymphoproliferative disorders: a proposed unified pathogenetic pathway.
    Ezdinli EZ; Nanus DM
    Hematol Oncol; 1983; 1(4):297-319. PubMed ID: 6429025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.